Health insurers, hospital groups and MedTech companies each face a distinct AI governance challenge — but the deadline is the same for everyone.
Health insurers deploying AI for claims processing, fraud detection and risk pricing fall under the same EU AI Act Annex III high-risk classification as financial insurers. The Dutch Healthcare Authority (NZa) expects demonstrably responsible AI use in healthcare administration. Organisations that do not address this now will fall behind on the August 2026 deadline.
The Integral Care Agreement (IZA) mandates digital transformation but provides no governance framework for AI implementation. Regional hospital groups lack the internal expertise to translate AI strategy into responsible clinical operations. The gap between the research environment and clinical practice is precisely where things go wrong.
AI-powered medical devices fall under the Medical Device Regulation and EU AI Act Annex I — a dual compliance obligation with an August 2027 deadline. Most MedTech companies understand the MDR. Few understand how the EU AI Act layers on top.